734 related articles for article (PubMed ID: 29671941)
1. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
4. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
[TBL] [Abstract][Full Text] [Related]
5. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
[TBL] [Abstract][Full Text] [Related]
6. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
7. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of smart stimuli-responsive mesoporous organosilica nano-vehicles for targeted pesticide delivery.
Liang Y; Gao Y; Wang W; Dong H; Tang R; Yang J; Niu J; Zhou Z; Jiang N; Cao Y
J Hazard Mater; 2020 May; 389():122075. PubMed ID: 31972522
[TBL] [Abstract][Full Text] [Related]
10. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
[TBL] [Abstract][Full Text] [Related]
11. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
[TBL] [Abstract][Full Text] [Related]
13. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of biodegradable auto-fluorescent organosilica nanoparticles with dendritic mesoporous structures for pH/redox-responsive drug release.
Li X; Chen Y; Zhang X; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110914. PubMed ID: 32409066
[TBL] [Abstract][Full Text] [Related]
15. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
[TBL] [Abstract][Full Text] [Related]
16. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
Wong RCH; Ng DKP; Fong WP; Lo PC
Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
[TBL] [Abstract][Full Text] [Related]
17. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
18. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
19. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
20. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
